Because it encourages the manufacturing of both the hormone and its receptors, zinc plays a critical function as a mediator in the binding of growth hormone to its receptor. The amount of zinc found in pancreatic tissue, which is rich, plays a part in regulating how insulin functions. Zinc has an impact on a variety of thyroid hormone metabolic processes, including hormone synthesis, receptor activation, T4-to-T3 conversion, and the production of carrier proteins. The important relationship between zinc and leptin is demonstrated by the fact that obese patients have low zinc levels and high leptin levels. Zinc is linked to the enzyme activity that produces melatonin. Zinc absorption by the gastrointestinal tract is controlled by melatonin. Zinc has a specific effect on this procedure because 5-reductase, a zinc-dependent enzyme, is involved in the transformation of testosterone into dihydrotestosterone. Zinc is known to have significant roles in the endocrine system as a result of these relationships 10. Zinc insufficiency has been linked in certain studies to decreased insulin production and increased tissue resistance to the effects of insulin 11. Insulin is kept in the pancreatic cells as a hexamer with two zinc ions, which is released when the cells degranulate 12. In situations of Zn, Se, and Cu deficiency, which may be brought on by ingesting too many processed foods, diabetes appears to be more prevalent 13. While zinc's (Zn) significance for normal biological processes and healthy development has long been understood, Zn has also been discovered to have insulin-mimicking and anti-diabetic characteristics. These insulin-like properties have been demonstrated in isolated cells, tissues, and several animal models of type 1 and type 2 diabetes 14. Diabetes and obesity are risk factors for a lack of zinc. But up until recently, the underlying molecular processes remained unknown. The groundbreaking discovery that frequent variation in the zinc transporter SLC30A8/ZnT8 may increase susceptibility to type 2 diabetes 15 shed light on the role of zinc in diabetes. In mice with diabetes caused by streptozocin or alloxan, zinc deficiency has not been seen. It is unknown how common zinc deficiency is among diabetes patients. In one research, 9% of NIDDM patients had blood Zn levels that were low (70 /Ag/dl). In this study, the nondiabetic comparator group's blood Zn levels varied from 70 to 120 ptg/dl. The decreased serum Zn levels in diabetic individuals are likely the consequence of hyperzincuria associated with diabetes and poor intestinal Zn absorption, even if the serum Zn levels may not be connected to blood glucose levels 1617. A lack of zinc may also make it more likely for someone to develop diabetes, insulin resistance, glucose intolerance, and coronary artery disease. Recent studies have demonstrated that zinc has beneficial benefits on insulin resistance, glucose and lipid profiles, and those with diabetes or metabolic syndrome. For instance, a prospective study found that American women who consumed more zinc had a lower risk of developing type 2 diabetes, and additional research revealed that people with type 2 diabetes who took zinc supplements had higher levels of HDL cholesterol and lower levels of triglycerides (TG) 18. A group of NIDDM and IDDM participants had lower blood plasma Zn concentrations, according to Walter et al. 19. Diabetes patients have also been discovered to have reduced Zn levels in their lymphocytes, granulocytes, and platelets 20. Due to a rise in those with diabetes or pre-diabetic symptoms, several research have been conducted to determine ways to lessen the effects of diabetes. One of the medicines that is most usually suggested for this usage is zinc (Zn). The benefits of zinc for type 1 and type 2 diabetes have long been established. With a focus on the length of therapy and ideal zinc dosage, this study aims to provide comprehensive information regarding the effects of zinc on the different signaling pathways in multiple tissues impacted by diabetes 21. Begin-Heick et al.'s 22 discovery that Zn supplementation reduced insulin hypersecretion in ob/ob mice is yet another proof that either the diabetic rodent's dietary Zn requirement is elevated or that chronic alterations in micronutrient metabolism are linked to aberrant function. In uncontrolled trials including senior participants, a positive impact of Zn supplementation on healing venous leg ulcers has been hypothesized 2324. Atypical Zn, Cu, and Fe metabolism can cause chronic disorders including diabetes and its complications. Compared to Cu and Zn shortage, these pathogenic illnesses appear to be more prevalent in Cu and Fe excess. When Fe and Cu are overloaded, diabetes and its effects may be controlled using chelating drugs 25.

A nutritional supplement and various foods, including nuts, seeds, vegetable oils, fruits, low-fat and fat-free milk, yogurt, cheese, and soy products, contain the fat-soluble vitamin E 28. There are eight different forms of vitamin E, but only alpha-tocopherol is found in human bodies32. In addition to its action as an antioxidant in the human body, vitamin E has been discovered to have a significant role in regulating blood sugar levels in diabetic patients. This is because, according to certain research, vitamin E therapy reduces insulin resistance and the glycemic index in people with type 2 diabetes 2930. In several research, vitamin E supplementation led to a noticeably lower HbA1c. Blood glucose was shown to be considerably lower following 8–10 weeks of vitamin E supplementation in addition to fasting blood glucose 2627. Studies have shown, among other things, that type 2 diabetes patients have lower levels of vitamin E than do other healthy persons 31. Given that several studies found lower plasma tocopherol levels in individuals with more advanced illness, its significance in diabetes is likely related to its antioxidant activity 3334. Vitamin E administration restored platelet thromboxane generation and aggregability in IDDM and NIDDM patients in double-blind studies 35. In rats and diabetic people, vitamin E supplementation may decrease glycosylation of glycohemoglobin, according to more recent evidence 3637. Both healthy control participants and 15 NIDDM patients had enhanced insulin action after receiving vitamin E supplementation (900 mg/dl for 4 months) 38. Patients with type 2 diabetes mellitus have been discovered to have lower levels of vitamin E among other vitamins 39. In the general population, high levels of -tocopherol have been linked to a lower incidence of diabetes, but not in middle-aged smokers 4041. A decrease in plasma tocopherol has been observed in diabetic subjects with a longer duration of the disease 4243, related to lipid peroxidation and cardiovascular complications 44, as well as with total cholesterol and central type obesity 45. Vitamin E's effect on the risk of diabetes and its complications is most likely due to its role as an antioxidant. However, in individuals with hemodyalisis-related diabetes, plasma tocopherol was not linked to death 46. Some vitamin supplementation trials with vitamin E and other vitamins, but not those with the haptoglobin 2-1 gene, have showed favorable effects on hypertension, blood glucose, antioxidant status, and HDL function in haptoglobin 2-2 genotype carriers 4748. The lipid profile and insulin sensitivity, however, were not affected, according to previous research 4951. In diabetic individuals who do not take vitamin E and other vitamin supplements, the risk of diabetes complications (hypertension, cardiovascular issues, central obesity, etc.) increases 51. However, as a diabetic complication, free radicals rise, increasing the diabetic patient's need for vitamin E and other antioxidants. Some research have sugested that vitamin E insufficiency is not a hallmark of diabetes complications 52. Additionally, patients with type 2 DM who get 900 mg/dl of vitamin E daily for four months will see improved insulin action 53.

As medical understanding of diabetes and its care has grown, it has become clear that managing and preventing diabetic complications calls for a diversified strategy. Interest in the possible function of vitamins, minerals, and vitamin C has increased recently 54. Ascorbic acid, another name for vitamin C, is a crucial nutrient with well-known antioxidant characteristics 55. The objective of this article is to evaluate the most recent research on the effects of vitamin C on diabetes while examining both its advantages and disadvantages. Numerous research have looked at the connection between vitamin C consumption and glycemic management in diabetics 5657. Antioxidant levels and vitamin C concentrations have been reported to be lower in diabetes patients compared to healthy controls 58. During the first two years of the illness, it has been discovered that newly diagnosed patients of type 2 diabetes mellitus have higher levels of lipid peroxidation and lower levels of antioxidant enzymes as well as vitamins C and E 59. Plasma vitamin C levels have been shown to be negatively linked with oxidative stress, fasting and postprandial blood glucose, and glycosylated hemoglobin, but not with lipid profiles 60. It is thought that vitamin C increases insulin sensitivity, which may help with better glucose control 61. According to a research by Luo et al. (2022), higher vitamin C intake in the diet was linked to lower HbA1c levels 62. However, there are inconsistent findings, with some studies demonstrating a little or insignificant impact on glycemic management. Vitamin C's antioxidant qualities are essential for reducing oxidative stress, which is linked to the pathophysiology of issues associated with diabetes 63. Reactive oxygen species (ROS) are produced in excess as a result of chronic hyperglycemia, which contributes to tissue damage. Due to its capacity to neutralize ROS, vitamin C may help lower the risk of developing diabetic complications such nephropathy, retinopathy, and neuropathy. However, more investigation is required to pinpoint a precise causal link. Diabetes development is linked to immunological dysfunction and inflammation. The immunomodulatory properties of vitamin C may have an influence on the inflammatory processes related to diabetes 64. According to several research, people with diabetes who take vitamin C supplements may have lower levels of inflammatory markers 65. However, to validate these results and clarify the underlying processes, further in-depth clinical investigations are required. Periodontal disease and diabetes have been linked, and dental procedures and vitamin C supplements have both been demonstrated to benefit chronic periodontitis. When type 2 diabetes patients first receive a diagnosis66. Vitamin C has also been demonstrated to lower diabetes-related anxiety levels, but not stress or depressive symptoms 67. Vitamin C and E treatment for three months lowered blood pressure and glucose levels while raising levels of superoxide dismutase and glutathione 68. According to a research conducted in India, people with diabetes had lower plasma ascorbate levels and greater plasma concentrations of dehydroascorbic acid than matched control patients 69. Ascorbic acid levels in the plasma of diabetic people in England and the U.S. are apparently normal 70. In non-selected NIDDM patients, supplementing with vitamin C at a dosage of 500 mg/dl for 15 days had no effect on blood glucose levels 71. Supplementation treatment (500–1,000 mg/day) has reportedly decreased hypercholesterolemia 72 and cutaneous vascular fragility 73 in patients with poor dietary ascorbic acid consumption. Although ascorbic acid supplementation (500 mg/day) had no impact on hyperlipidemia, one trial in an unselected group revealed that it did not 74.

A macronutrient that is classified as a micronutrient that is crucial for growth and development is iron. Increased iron levels create oxidative stress, which is primarily brought on by the Fenton reaction and harms the body's regular physiological functions. The unidentified buildup of extra iron in tissue, which results in oxidative stress, is the mechanism through which inherited high iron levels induce cardiomyopathy, liver cirrhosis, and diabetes. The average adult male body has 5 grams of iron, of which 65% is found in the hemoglobin iron form at RBC. The remaining iron is utilized for cellular enzymatic activities and is stored in the liver, spleen, and bone 75. Although the exact mechanism of iron-induced diabetes is unknown, three mechanisms Insulin resistance, insulin insufficiency, and hepatic dysfunction are possible contributing factors. Oxidative stress in the pancreatic beta cells is the source of insulin insufficiency, and decreased hepatic function is the direct or indirect cause of insulin resistance 76. Ferritin levels range from 1000 to 10,000 ng/ml in people with hereditary hemochromatosis who have diabetes type 2 and circulate insulin. Diabetes in HH is brought on by both insulin resistance and insufficiency 77. Wei Boa's study revealed that type 2 diabetes was positively correlated with body stores of iron and excess dietary iron. According to the meta-analysis, supplementary iron, non-heme iron, and total iron consumption all directly affect the prevalence of type 2 diabetes. Red, the main supplementary iron source, may be the root of type 2 diabetes 78. Hepatocytes, in circumstances of food excess consumption, or macrophages, in cases of hemolytic responses, are involved in an elevated degree of insulin resistance without any injury to the tissue, which increases insulin resistance in type 2 diabetes. Additionally, a research by Forouhi et al. found that the ferritin level in plasma, which has a baseline level of 360 and is greater in those with diabetes than 758, is the greatest predictor of the development of diabetes 79.

In recent years, our understanding of the physiological function of vitamin K has grown to encompass a variety of other facets of human health in addition to its control of coagulation.Phylloquinone (VK1) and menaquinone (VK2) are two naturally occurring forms of vitamin K that are available in many foods, particularly leafy greens and dairy products, and are libid-soluble vitamins 8081.Numerous studies have demonstrated the significance of vitamin K in controlling insulin resistance, glycemic state, and glucose metabolism. In a Spanish study 82, researchers looked at the correlation between dietary vitamin K consumption and diabetes-related indicators. Initial research revealed no correlations between the baseline values. The plasma concentrations of ghrelin, glucose-dependent insulinotropic peptide, glucagon-like peptide-1, IL-6, leptin, TNF, and visfatin were lower in people with increased vitamin K intakes after a year of follow-up. Interestingly, this study also found that higher vitamin K intakes were associated with a lower risk of acquiring diabetes mellitus 83. Another study examined the relationship between vitamin K consumption and the occurrence of type 2 diabetes mellitus over a period of around 10 years by doing a retrospective analysis of a Dutch database. The results showed a negative correlation between the intake of phylloquinone and menaquinone with the incidence of diabetes 84.

No proof was found to support the effect of phylloquinone in a comprehensive analysis by Rees et al. that looked at the effects of vitamin K intake or deficiency on cardiovascular disease, type 2 diabetes, and the metabolic syndrome. Menaquinones, according to the review, could help lower the chance of developing these illnesses 85. The use of vitamin K has been linked in several studies to insulin sensitivity, glucose metabolism, and ultimately diabetes. In the Spanish PREDIMED study, for instance, plasma concentrations of ghrelin, glucose-dependent insulinotropic peptide, glucagon-like peptide-1, IL-6, leptin, TNF, and visfatin were lower in subjects with the highest intakes after one year of follow-up compared to subjects with the lowest intakes. Baseline values did not show any associations between these markers. Increased vitamin K intakes were found to reduce the incidence of diabetes mellitus in this same research 8687. Following about 10 years of follow-up, a retrospective Dutch database study of vitamin K consumption and the prevalence of type 2 diabetes mellitus discovered that phylloquinone and menaquinone intakes were negatively correlated with the risk of acquiring diabetes 88. Menaquinones may play a role in lowering risk, according to Rees et al. 89, who conducted a systematic review of studies that assessed associations between vitamin K deficiency or intake and cardiovascular disease, type 2 diabetes, and the metabolic syndrome. They found no evidence of phylloquinone's effect.

Although the routes are unknown, vitamin D has been shown to have a function in glucose homeostasis 90. Vitamin D3 is produced in the skin when exposed to ultraviolet B light from the sun. When skin is exposed to solar UVB radiation, 7-dehydrocholesterol in the skin is transformed to pre-vitamin D3, and this non-enzymatic, heat-dependent process culminates in the rapid conversion of pre-vitamin D3 to vitamin D3 91. The vitamin D receptor (VDR) is found in multiple organs, which implies that vitamin D metabolites may have a wide range of non-skeletal effects. Pancreatic beta-cells contain the VDR 909192. Beta cell development and differentiation may be influenced by the active vitamin D metabolite 92. According to preclinical studies, vitamin D controls the calcium flow inside beta cells, the survival of beta cells, and insulin production. Numerous investigations have shown that rat pancreatic beta cells' capacity to release insulin in response to glucose is impacted by vitamin D deficiency, whereas vitamin D supplementation appears to enhance this capacity 91. Vitamin D regulates the immune system's early development and is crucial for the healthy emergence and maintenance of self-tolerance. Autoimmunity is more likely when vitamin D signaling is impaired, particularly in youth 93. Both animal research and observational studies have shown a correlation between a reduced level of 25-hydroxyvitamin D (25OHD) in the blood and an increased risk of type 1 diabetes 94. Low circulating vitamin D levels and type 1 diabetes are closely related 93. Type 1 diabetes is less likely to occur in children who get enough vitamin D throughout pregnancy and infancy 9193. Vitamin D insufficiency has been associated to metabolic syndrome and type 2 diabetes mellitus 92. The majority of cross-sectional observational studies that have looked at the connection between vitamin D status and the incidence of type 2 diabetes have concluded that there is a negative correlation between vitamin D status (25OHD concentration) and diabetes 91. In those with prediabetes, vitamin D treatment reduces the incidence of T2DM and speeds up the process by which prediabetes turns into normoglycemia 959697. It has been demonstrated that vitamin D supplementation lowers insulin resistance 98. In accordance with ES recommendations, daily oral vitamin D dosages lower HbA1c levels over three and six months 99. Cells of the immune system and the pancreas both have vitamin D receptors. Vitamin D participates in the activity of -cell endopeptidases that depend on calcium and can act through two main pathways: either directly inducing cells to secrete insulin through an increase in intracellular calcium concentration through Ca channels or by mediating -cell calcium-dependent activation to facilitate the conversion of pro-insulin to insulin 100101. Vitamin D is also well known for its role in the regulation of calcium absorption. However, some interventional trials have shown that supplementing with vitamin D does not improve metabolic parameters, but rather alters adipokine concentrations, reduces pro-inflammatory cytokines like TNF-, and some other parameters like natriuretic peptide concentrations and blood pressure in diabetic patients 102103. Even years of follow-up were not able to reduce the incidence of diabetes, according to other research 104105106107108. The interaction of 1,25-dihydroxyvitamin D with its beta cell receptors can facilitate communication between cells. Alternately, vitamin D can improve insulin sensitivity by directly increasing insulin receptor expression and activating PPAR- (peroxisome proliferator activated receptor delta), which has been linked to the regulation of fatty acid metabolism in skeletal muscle and adipose tissue 108109110111. This mechanism involves the activation of 25 hydroxyvitamin D (25OHD) by 1-alpha-hydroxylase expressed in pancreatic beta cells. Additional research has revealed links between insulin resistance, -cell dysfunction, and blood vitamin D levels. Even though this interaction has only been seen in females, further research is likely required to determine whether there is a connection between sex hormones, vitamin D, adipose tissue, and -cell function 112113114115116.

A water-soluble vitamin in the vitamin B complex is thiamine, sometimes known as vitamin B1. Whole grains, enriched bread, whole cereal, legume seeds, certain fruits and vegetables, the yolk of eggs, liver, and meat all contain it. The thiamine diphosphokinase enzyme changes it into thiamin pyrophosphate, which is the physiologically active form. It is a vital component that supports the Krebs cycle, the metabolism of carbohydrates and amino acids, and is a strong antioxidant. It offers a crucial element in the development of the brain and neurotransmitters. Thus, Wernicke-Korsakoff syndrome, a neurological condition, might result from its deficit. Memory loss, ataxia, and psychosis are all signs of this illness. Beri-Beri illness and visual neuropathy can result from a deficiency 117118119. Thiamine pyrophosphate is essential for carbohydrate metabolism. It functions as a cofactor for alpha-ketoglutarate, pyruvate dehydrogenase, and transketolase. These enzymes control the Krebs cycle and glycolysis. Thiamine deficiency results in anaerobic glycolysis, which results in the creation of lactic acid or the buildup of glucose in the circulation 122. Benfotiamine, a lipid-soluble thiamine derivative, aids in the release of insulin by pancreatic cells 125. reported increased plasma thiamine levels in people with diabetes of an undefined kind and linked this to reduced thiamine tissue transport 128. Be aware that diabetic people's erythrocyte transketolase activity has been shown to be decreased, regardless of their thiamine status 129. The specific processes through which nicotinamide exerts its protective effects are unknown. A recent double-blind, randomized clinical research, however, found no evidence of nicotinamide's ability to help patients with early-onset IDDM remission 130. Numerous research have been conducted to find out how much thiamine can influence glycemic management in people with type 2 DM because of its important involvement in carbohydrate metabolism and insulin generation. In 2021, a systematic review was carried out to evaluate these research. There were six studies totaling 364 patients enrolled. They had 100–900 mg of thiamine per day. Thiamine has no effect on glycemic management in those with type 2 diabetes, according to the review. But it has a favorable impact on the lipid profile. As HDL levels rose, triglyceride levels dropped 121. Thiamine and riboflavin supplementation reduces the chance of developing gestational diabetes, according to a second trial with 3036 pregnant women 123. Nephropathy, the inforeased Diabetes macro-own bmicro-vascular complications, such as retinopathy, nephropathy, and neuropathy, due to an increase in the levels of the glycolytic metabolites glyceraldehyde 3 phosphate and fructose 6 phosphate, need further confirmation from additional studies. Reactive oxygen species build up as a result of these metabolites entering four pathways: the synthesis of advanced glycation end products (AGE), the diacylglycerol-protein kinase C (PKC), polyols, and hexosamine. By blocking three pathways (AGE, hexosamine, and the diacylglycerol (DAG)-protein kinase C (PKC) pathway), benfotiamine can prevent these issues. It is a cofactor for the enzyme transketolase, which converts pentose 5 phosphate and erythrose 4 phosphate from fructose 6 phosphate and glyceraldehyde 3 phosphate 124126127. Thiamine is required by the body in greater amounts in diabetes individuals due to its advantageous effects. Thiamine levels are lower in diabetic patients than in healthy individuals 120. Both Type 1 and Type 2 diabetes patients have been observed to have low levels of thiamine and increased renal clearance 131. Thiamine levels were lower in diabetics, with a gradual decline with albuminuria, especially so in macroalbuminuria, in a cross-sectional comparative investigation of normal controls and microalbuminuric and macroalbuminuric DM patients. A number of thiamine supplementation studies have been carried out with beneficial outcomes. Microalbuminuria was found to have a negative connection between thiamin and lipid profiles 132. For instance, it has been demonstrated that giving diabetic patients thiamine for a month lowers their glucose and leptin levels compared to controls 133. In a double-blind, placebo-controlled trial, Rabbani et al examined diabetic individuals with microalbuminuria and the subsequent decrease in urine albumin excretion following a three-month intervention 134.

Niacin, an important B vitamin, plays a substantial role in decreasing low-density lipoprotein (LDL), lowering plasma TG, and raising HDL. Niacin may be useful in controlling cholesterol levels for secondary prevention as a stand-alone therapy, especially for people who cannot tolerate statins. The underlying data, however, comes from earlier research done on a group that might not fully represent patients today. Niacin reduces the production of triglycerides, very low-density lipoprotein, and LDL cholesterol largely by limiting the release of fatty acids from adipose tissue. Niacin also appears to increase HDL cholesterol levels via boosting reverse cholesterol transport and reducing hepatic apolipoprotein A-I clearance. In the pharmaceutical industry, nicotinic acid is used to treat hyperlipidemia when given in large doses 135136. It is possible that these lipid-modifying processes speed up the development of atherosclerosis in people with diabetes. It is noteworthy that people with diabetes have higher amounts of cell adhesion molecules (CAM), which are crucial to the many pathways of atherogenesis. When viewed in the context of atherosclerosis processes, this increased expression of CAMs in diabetes is particularly significant. It has been demonstrated that niacin reduces the risk of cardiovascular disease and death. In addition to its well-known lipid-modifying qualities, it has shown substantial advantages in this area 137. A research was conducted to see how nicotinic acid (NA) affected the drop in plasma glucose levels. Participants were given continuous infusions of NA, somatostatin (SRIF), a combination of NA and SRIF, or a saline solution containing 0.9% NaCl throughout the duration of the experiment. The results showed that both NA and NA + SRIF infusions significantly reduced plasma non-esterified fatty acid (NEFA) concentrations, successfully bringing them down to around one-fourth of their starting levels. All of these results suggest that nicotinic acid has potential for lowering plasma glucose levels in healthy persons. This impact is thought to be mostly due to the contemporaneous decline in plasma NEFA levels. Niacin's interaction with diabetes creates a complex situation. Niacin, which is well known for its potential benefits in lipid management, but bears the risk of negative effects on glucose metabolism, which might make glycemic control in people with diabetes more difficult. Therefore, it is essential to use a patient-specific strategy and carefully weigh the risks and benefits of niacin treatment in such situations. The Coronary Drug Project found that supplementing with niacin increased the risk of type 2 diabetes mellitus in subjects with impaired fasting glucose (IFG), normoglycemia, or both. On the other hand, adverse effects have also been linked to niacin supplementation 139. According to Zhou et al, nicotinamide excess caused by an increase in the population's consumption of niacin, thiamin, and riboflavin through food fortification may be linked to oxidative stress and insulin resistance, having a detrimental impact on the emergence of complications related to type 2 diabetes mellitus 140.

The physiologically active form of vitamin B6 is pyridoxal 50-phosphate (PLP), which serves as a coenzyme in around 160 distinct enzymatic processes, the majority of which are involved in amino acid, carbohydrate, and lipid metabolism. It also has significant effects on the production and/or breakdown of a variety of neurotransmitters. By stifling oxygen reactive species (ROS) and halting the production of advanced glycation end products (AGEs), genotoxic compounds associated with aging and diabetes ^141–143, PLP also serves as an antioxidant molecule. Its absence has been related to a number of clinically relevant diseases, including as autism, schizophrenia, Alzheimer's, Parkinson's, epilepsy, Down's syndrome, diabetes, and cancer, though the underlying processes are largely unclear 142. PLP deficiency has been associated to a variety of human diseases, including diabetes 141142144. Epidemiological and experimental studies established a clear negative relationship between vitamin B6 levels and diabetes as well as a preventative impact of vitamin B6 on diabetic complications 142. Rats with decreased insulin production due to PLP deficiency benefit from PLP supplementation in terms of improved gestational diabetes and avoided diabetic complications. Numerous studies showed that people with diabetes who took vitamin B6 supplements had much less neuropathy 141144145. Tanimoto and colleagues report for the first time in this issue of Metabolism that pyridoxamine (K-163) supplementation elevates blood 3-deoxyglucosone levels and urine albumin-to-creatinine ratios in KK-Ay/Ta mice, an animal model for type 2 diabetic nephropathy that develops spontaneously. The bilayer of the cell membrane, the vessel wall, the proteins, lipids, and even the cell's nucleic acids can all be harmed by this free radical if it is not quickly neutralized by an antioxidant like vitamin B6 146. Hyperglycemia and hyperketonemia, both of which produce reactive oxygen species. Vitamin B6 has an antagonistic relationship with diabetes 141. Amino acids can be converted into a source of energy by either transaminase or a deamination process, both of which are mostly performed by pyridoxal-dependent enzymes. Only PL was discovered in the plasma of diabetic rats compared to controls due to an increase in alkaline phosphatase, while vitamin B6 was largely present in the forms of PLP and PL. It is possible that more vitamin B6 was absorbed into the liver in diabetic rats since their plasma vitamin B6 levels were much lower than those of the controls. The amount of vitamin B6 would increase in the liver of diabetic rats due to the activation of AST and other transaminases. The amount of vitamin B6 would increase in the liver of diabetic rats due to the activation of AST and other transaminases 143. Whether low PLP levels are a result of, a cause of, or a combination of diabetes is not understood, though. investigations have revealed that low PLP levels can result from diabetes, whereas other investigations have showed that PLP levels are decreased by diabetes 141142. The plasma pyridoxal 50-phosphate (PLP) concentration is routinely used to measure vitamin B6 levels. An insufficient status of vitamin B6 is often indicated by a concentration below the threshold of 30 nmol/L 142. The consequences of pyridoxal 50-phosphate shortage on diabetes may vary. For instance, PLP could have an impact on the process that converts tryptophan into nicotinic acid since it is a cofactor of some of the enzymes involved in that system. It has been proven that the metabolites produced when this route is defective may interfere with the biological action of insulin, resulting in insulin resistance, a defining feature of type 2 diabetes. According to a hypothesis, PLP may influence insulin resistance by controlling the expression of genes related to fat tissue. According to a different notion, homocysteine levels may increase due to decreased cystathionine-b-synthase (CBS) and cystathionine-g-lyase (CGL) enzymes, both of which need PLP as a cofactor, if PLP is deficient 141142. It has been demonstrated that animals deficient in vitamin B6 had reduced pancreatic and blood levels of insulin. Deficiency has been connected to declining changes in the h-cells in the islets of Langerhans and impaired glucose tolerance 144. Eight months to 28 years of follow-up on 18 people with diabetes mellitus who had varied levels of steroid and vitamin B6 medication, some of whom had retinopathy, were pregnant, or had carpal tunnel syndrome. A connection between a vitamin B6 deficiency and diabetes has been demonstrated by examining the specific activity of the erythrocyte glutamic oxaloacetic transaminase and once again by the linkage with the carpal tunnel syndrome. It has been known for 10 years that CTS and a B6 deficiency are related 147. An adversarial link exists between vitamin B6 levels and diabetes, according to an analysis of the research described in the literature. According to Satyanarayana and colleagues' cross-sectional case-control research 148, the mean plasma PLP levels in T2D individuals were significantly lower than in healthy controls. Comparing the findings of Ahn and colleagues from a Korean research with those of Nix and associates from a German cohort suggested an inverse relationship between vitamin B6 levels and the development of diabetes 149150. The advanced clinical stage diabetes group Nix investigated showed median plasma concentrations of PLP, PN, and PL that were considerably lower in the diabetic group in comparison to the controls 150. Ahn and colleagues, who looked at diabetics with an early stage of the illness, discovered that a decrease in the mean plasma PLP level was important but not statistically significant compared to controls 149. The discovery that median plasma levels of PM, PMP, and pyridoxic acid were significantly higher in the diabetes groups than in the controls led Nix and colleagues to advance the theory that T2D may be connected to a changed activity of the enzymes involved in the interconversion of B6 vitamins 150. Another study made the assumption that reduced vitamin B6 levels in T2D individuals might be the consequence of flawed reabsorption mechanisms based on the data showing increased vitamin B6 urine clearance. Falling PLP levels have also been connected to GDM. PLP levels were lower than anticipated in 13 of 14 women with GDM who took part in a research by Bennink and Schreurs ^151–153. According to results from other intervention studies, pyridoxine supplementation can reduce glycosylated hemoglobin levels in type 2 diabetics and blood glucose levels in streptozotocin-treated rats. According to studies by Kim and colleagues 154, vitamin B6 can also reduce postprandial blood glucose levels after ingesting sucrose and starch by inhibiting the activity of small-intestinal _-glucosidases. In this investigation, the role of vitamin B6 (pyridoxine) treatment in pregnant people with gestational diabetes was examined. According to the current study, vitamin B6 treatment enhanced glucose tolerance in a single, small sample. Except for the 5-minute sample, all of the individual glucose readings have significantly decreased following the B6 administration. Additionally, treatments were used to lower 38.5% of the fasting blood glucose readings to acceptable levels (90 mg per 100 ml). The blood glucose profiles that accompanied the medication as a result demonstrated a discernible improvement 155. Finally, compelling evidence demonstrates the undeniable connection between vitamin B6 and diabetes through a number of mechanisms and pathways 142. These results could indicate that diabetic animals need to eat extra vitamin B6 since diabetes might lead to a vitamin B6 deficit 143. On the other hand, this study, which was a 30-year follow-up study, found a negative correlation between the risk of diabetes with folate consumption but not with vitamin B12 or pyridoxine. It has been suggested that diabetics who don't get enough nourishment from their diets may only benefit from nutritional supplements. The benefits of these two B vitamins on the risk of acquiring diabetes would not be as great as those of folate, according to this argument, which could assist to explain why the current investigation did not find an association between vitamin B6 and B12 consumption and the incidence of diabetes 156.

Scientific evidence supports the importance of the vitamin B9 folate in preventing and controlling diabetes mellitus 157158. Folate participates in a number of metabolic processes, including insulin control and glucose metabolism. According to research, consuming enough folate may increase insulin sensitivity, lowering the chance of developing insulin resistance, a characteristic of type 2 diabetes 157. According to a research in Diabetes Care 2018, those with greater levels of folate had a decreased chance of getting type 2 diabetes, but folate deficiency has been linked to a higher risk of getting diabetes 161. Additionally, a systematic review and meta-analysis that was published in the American Journal of Clinical Nutrition in 2018 discovered that adults with type 1 and type 2 diabetes mellitus and prediabetes in the US had a lower risk of dying from cardiovascular disease when their dietary folate intake was higher 159160. This shows that dietary folate may enhance glycemic management and prevent diabetes in general. Although further investigation is required to completely understand the processes underlying folate's effects on diabetes, the available scientific evidence highlights the promise of this vitamin as a dietary component in the prevention and management of this widespread metabolic illness.

Cobalamin, the physiologically active form of vitamin B12, is a micronutrient also known as cyanocobalamin. Adenosyl cobalamin, a cofactor of the enzyme methionine synthase, and methyl cobalamin, a cofactor of mutase, are the two active forms that result from its subsequent metabolism. Yoshiatsu Takahashi et al. investigated the metabolism of vitamin B12 in 19 diabetic patients with impaired glycemic control and 15 healthy individuals. Its insufficiency may cause a variety of complications, including megaloblastic anemia, insulin resistance, hyperhomocysteinemia, defective neurotransmitter synthesis, impaired cognition, cardiovascular diseases, and neurological complications 161. They found a greater correlation between diabetes patients' blood fructosamine levels and total vitamin B12 binding ability. This demonstrates the link between glycemic management and vitamin B12 metabolism in people with diabetes mellitus 162. The effect of vitamin B12 on type 2 diabetes mellitus patients was confirmed in a randomized, multi-arm, open-labeled clinical trial involving 80 type 2 diabetes mellitus patients who were divided into 4 groups with 20 patients each and observed for 8 weeks 163. These groups who received vitamin B12 supplements demonstrated improved glycemic control and reduced insulin resistance. When analyzing the plasma concentration level of vitamin B12 in 913 pregnant women during the 26th gestational week, Jun S. Lai et al. reported a higher prevalence of gestational diabetes mellitus among people with a combined insufficiency of vitamin B12 (48%) and high folate concentration 164. A meta-analysis research comprising 1810 pregnant women, 309 of whom had gestational diabetes mellitus, revealed similar findings. The findings support a somewhat greater link between vitamin B12 deficiency and an increased risk of developing gestational diabetes mellitus 165. According to Elizabeth Kos et al., a retrospective assessment of patient medical data revealed that metformin-treated individuals had statistically lower vitamin B12 levels than non-treated patients. This suggests that type 2 diabetes individuals taking metformin have a greater prevalence of vitamin B12 insufficiency 166. Likewise, Valdos-Ramos, Roxana, et al. reported it. Their review research found a greater frequency of vitamin B12 deficiency in type 2 diabetes mellitus patients receiving metformin treatment, since metformin use for an extended period of time decreases vitamin B12 absorption, resulting in vitamin B12 insufficiency in such individuals 167. Diabetic foot ulcers are another problem brought on by a vitamin B12 deficiency. A substantially greater correlation between vitamin B12 deficiency and diabetic foot ulcers in type 2 diabetes mellitus patients was found in Mohammed Badedi et al.'s case-control study of 323 type 2 diabetes mellitus patients, including 108 patients with diabetic foot ulcers 168. Patients with type 1 and type 2 diabetes mellitus have been found to have a greater frequency of clinical and biochemical vitamin B12 insufficiency 169. Patients with type 2 diabetes mellitus frequently have insomnia, which appears to be related to higher vitamin B12 levels. The findings of a cross-sectional research by Shuyuan Xiong et al. among 418 type 2 diabetes mellitus patients, where 24.16 percent of them reported experiencing insomnia, point to an independent contribution to insomnia in type 2 diabetes mellitus patients 170.

1. Glucagon-like peptide-1 : GLP-1

2. T2DM : Type 2 of diabetes

3. T1DM : Type 1 of diabetes

4. Gestational diabetes mellitus (GDM)

5. Non-insulin-dependent diabetes mellitus (NIDDM) 

6. Insulin dependent diabetes mellitus (IDDM)

7. HbA1c :a blood test that is used to diagnose type 2 diabetes

8. Reactive oxygen species (ROS)

9. RBC : Red Blood Cell

10. diacylglycerol (DAG)-

11. protein kinase C (PKC)

12. ow-density lipoprotein (LDL),

13. cell adhesion molecules (CAM)

14. nicotinic acid (NA)

15. non-esterified fatty acid (NEFA)

16. impaired fasting glucose (IFG)cell adhesion molecules (CAM

17. CTS carpal tunnel syndrome cystathionine-b-synthase (CBS) and cystathionine-g-lyase (CGL) plasma pyridoxal 50-phosphate (PLP)

18. oxygen reactive species (ROS)